Activation of the cannabinoid CB1 receptor may involve a W6.48/F3.36 rotamer toggle switch

Journal of Peptide Research

Volumn 60, Issue 6, 2002, Pages 357-370

  Singh, R ^a   Hurst, D P ^a   Barnett Norris, J ^a   Lynch, D L ^a   Reggio, Patricia H ^a   Guarnieri, F ^b  

^a KENNESAW STATE UNIVERSITY   (United States)

^b NONE

Author keywords

Activation; Cannabinoid; GPCR; TMH 6

Indexed keywords

CANNABINOID 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR;

ARTICLE; CALCULATION; CONFORMATIONAL TRANSITION; HUMAN; MONTE CARLO METHOD; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SPECTROSCOPY;

AMINO ACID SEQUENCE; AMINO ACIDS, AROMATIC; COMPUTER SIMULATION; HUMANS; HYDROGEN BONDING; MEMBRANE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MONTE CARLO METHOD; MUTATION; PROBABILITY; PROLINE; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RHODOPSIN; ROTATION; THERMODYNAMICS;

CANNABIS;

EID: 0036954833     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2002.21065.x     Document Type: Article

References (35)

1. Gerard, C.M., Mollereau, C., Vassart, G. & Parmentier, M. (1997) Molecular cloning of a human brain cannabinoid receptor which is also expressed in testis. Biochem. J. 279, 129-134.
2. Munro, S., Thomas, K.L. & Abu-Sharr, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
3. Bouaboula, M., Perrachon, S., Milligan, L., Carrat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., Maffrand, J.P., Lefur, G. & Casellas, P. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J. Biol. Chem 272, 22330-22339.
4. 2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol. 54, 1064-1072.
5. Meschler, J.P., Kraichely, D.M., Wilken, G.H. & Howlett, A.C. (2000) Inverse agonist properties of N-(piperidin-1-yl) -5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB (1) cannabinoid receptor. Biochem. Pharmacol. 60, 1315-1323.
6. Mato, S., Pazos, A. & Valdizan, E.M. (2002) Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain. Eur J. Pharmacol. 443, 43-46.
7. Han, M., Smith, S.O. & Sakmar, T.P. (1998) Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6. Biochemistry 37, 8253-8261.
8. Fattens, D.L., Altenbach, C., Yang, K., Hubbell, W.L. & Khorana, H.G. (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274, 768-770.
9. 2 adrenoceptor. EMBO J. 16, 6737-6747.
10. Ghanouni, P., Steenhuis, J.J., Farrens, D.L. & Kobilka, B.K. (2001) Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Proc. Natl Acad. Sci. USA 98, 5997-6002.
11. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., LeTrong, I., Teller, D.C., Okada, T., Stenkamp, R.E., Yamamoto, M. & Miyano, M. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745.
12. Ballesteros, J.A., Jensen, A.D., Liapakis, G., Rasmussen, S.G.F., Shi, L., Gether, U. & Javitch, J.A. (2001) Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem 276, 29171-29177.
13. Visiers, I., Ebersole, B.J., Dracheva, S., Ballesteros, J., Sealfon, S.C. & Weinstein, H. (2002) Structural motifs as functional microdomains in G-protein-coupled receptors: Energetic considerations in the mechanism of activation of the serotonin 5-HT2A receptor by disruption of the ionic lock of the arginine cage. Int. J. Quant Chem 88, 65-75.
14. Jensen, A.D., Guarnieri, F., Rasmussen, S.G.F., Asmar, F., Ballesteros, J.A. & Gether, U. (2001) Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling. J. Biol. Chem 276, 9279-9290.
15. Borham, B., Souto, M.L., Imai, H., Shichida, Y. & Nakanishi, K. (2000) Movement of retinal along the visual transduction path. Science 288, 2209-2212.
16. Lin, S.W. & Sakmar, T.P. (1996) Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state. Biochemistry 35, 11149-11159.
17. Shi, L., Liapakis, G., Xu, R., Guarnieri, F., Ballesteros, J.A. & Javitch, J. (2002) Beta-2-adrenergic receptor activation: Modulation of the proline kink in TM6 by a rotamer toggle switch. J. Biol. Chem, 277, 40989-40996.
18. Javitch, J.A., Fu, D., Liapakis, G. & Chen, J. (1997) Constitutive activation of the beta-2-adrenergic receptor alters the orientation of its sixth membrane-spanning segment. J. Biol. Chem 272, 18546-18549.
19. Barnett-Norris, J., Hurst, D.P., Buehner, K., Ballesteros, J.A., Guarnieri, F. & Reggio, P.H. (2002) Agonist alkyl tail interaction with cannabinoid CB1 receptor V6.43/16.46 groove induces a helix 6 active conformation. Int. J. Quantum Chem 88, 76-86.
20. Ballesteros, J.A., Weinstein, H. (1995) Integrated methods for the construction of three dimensional models and computational probing of structure function relations in G protein-coupled receptors. (P.M. Conn & S.C. Sealfon, eds.) Methods In Neuroscience 25, 366-428.
21. Guarnieri, F. & Weinstein, H. (1996) Conformational Memories and the exploration of biologically relevant peptide conformations: An illustration for the gonadotropin-releasing hormone. J. Am. Chem Soc. 118, 5580-5589.
22. Mohamadi, F., Richards, N.G.J., Guida, W.C., Lizkamp, R., Lipton, M., Caulfield, C., Chang, G., Hendickson, T. & Still, W.C. (1990) Macromodel-An Integrated Software System for Modeling Organic and Bioorganic Molecules Using Molecular Mechanics. J. Comp Chem 11, 440-467.
23. Visiers, I., Braunheim, B.B. & Weinstein, H. (2000) ProKink: a protocol for numerical evaluation of helix distortions by proline. Protein Eng 13, 603-606.
24. Bramblett, R.D., Panu, A.M., Ballesteros, J.A. & Reggio, P.H. (1995) Construction of a 3D model of the cannabinoid CB1 receptor: determination of helix ends and helix orientation. Life Sci. 56, 1971-1982.
25. Gunasekaran, K., Nagarajaram, H.A., Ramakrishnan, C. & Balaram, P. (1998) Stereochemical punctuation marks in protein structures: glycine and proline containing helix stop signals. J. Mol Biol. 275, 917-932.
26. Hunter, C., Singh, J. & Thornton, J. (1991) Pi-pi interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins. J. Mol. Biol. 218, 837-846.
27. Burley, S. & Petsko, G. (1985) Aromatic-aromatic interaction: a mechanism of protein structure stabilization. Science 229, 23-28.
28. Chen, S., Lin, F., Xu, M. & Graham, R.M. (2002a) Phe (303) in TMVI of the alpha (1B)-adrenergic receptor is a key residue coupling TM helical movements to G-protein activation. Biochemistry 41, 588-596.
29. Chen, S., Lin, F., Xu, M., Riek, R.P., Novotny, J. & Graham, R.M. (2002b) Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations. Biochemistry 41, 6045-6053.
30. Han, M., Lin, S.W., Minkova, M., Smith, S.O. & Sakmar, T.P. (1996) Functional interaction of transmembrane helices 3 and 6 in rhodopsin. Replacement of phenylalanine 261 by alanine causes reversion of phenotype of a glycine 121 replacement mutant. J. Biol. Chem 271, 32337-32342.
31. Chen, S., Xu, M., Lin, F., Lee, D., Riek, P. & Graham, R.M. (1999) Phe310 in transmembrane VI of the alpha1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding. J. Biol. Chem 274, 16320-16330.
32. Hurst, D., Lynch, D.L., Barnett-Norris, J., Hyatt, S.M., Seltzman, H.H., Zhong, M., Song, Z.-H., Nie, J., Lewis, D. & Reggio, P.H. (2002) SR141716A interaction with. Lys 3. 28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor. Mol. Pharmacol, in press.
33. Kearn, C.S., Greenberg, M.J., DiCamelli, R., Kurzawak, K. & Hillard, C.J. (1999) Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange. J. Neurochem. 72, 2379-2387.
34. McAllister, S., Tao, Q., Barnett-Norris, J., Buehner, K., Hurst, D., Guanieri, F., Reggio, P., Nowell-Harmon, K., Cabral, G. & Abood, M. (2002) A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition. Biochem. Pharmacol. 7260, 1-16.
35. Hulme, E.C., Lu, Z.-L., Ward, S.D.C., Allman, K. & Curtis, C.A.M. (1999) The conformational switch in 7-transmembrane receptors: the muscarinic receptor paradigm. Eur J. Pharmacol. 375, 247-260.